US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

PDI Povidone-Iodine Swabstick

Reason SubPotent: Out of Specification

Professional Disposables International, Inc NDC 10819-3885-2 D-0761-2021
Class II · Moderate risk Terminated

PDI Povidine Iodine Swabstick

Reason SubPotent: Out of Specification

Professional Disposables International, Inc NDC 10819-3885-1 D-0760-2021
Class II · Moderate risk Terminated

PDI Povidone-Iodine Prep Pad Large

Reason SubPotent: Out of Specification

Professional Disposables International, Inc NDC 10819-3883-3 D-0759-2021
Class II · Moderate risk Terminated

PDI Povidone-Iodine Prep Pad MEDIUM

Reason SubPotent: Out of Specification

Professional Disposables International, Inc NDC 10819-3883-1 D-0758-2021
Class II · Moderate risk Terminated

Econazole Nitrate Cream 1%

Reason Correct Labeled Product Mispack

Teligent Pharma, Inc. NDC 52565-022-85 D-0751-2021
Class II · Moderate risk Terminated

Tizanidine HCl Tablets

Reason Failed Tablet/Capsule Specification: Some tablets are shaved

Dr. Reddy's Laboratories, Inc. NDC 55111-180-15 D-0750-2021
Class II · Moderate risk Terminated

QiYu Hand Sanitizer

Reason Subpotent

Native Promotions, INC D-0793-2021
Class II · Moderate risk Terminated

Sulfamethoxazole and Trimethoprim Tablets

Reason Presence of Foreign Substance- Potential of metal contamination.

Aurobindo Pharma USA Inc. NDC 65862-420-05 D-0719-2021
Class II · Moderate risk Terminated

NIFEdipine EXTENDED-RELEASE TABLETS

Reason Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.

The Harvard Drug Group NDC 0904-7080-61 D-0652-2021
Class II · Moderate risk Terminated

Global Hand Sanitizer with moisturizer

Reason CGMP Deviations: Does not meet monograph for denaturant.

Cascade Kelly Holdings LLC NDC 80253-001-02 D-0698-2021
Class II · Moderate risk Terminated

Global Hand Sanitizer with moisturizer

Reason CGMP Deviations: Does not meet monograph for denaturant.

Cascade Kelly Holdings LLC NDC 80253-001-01 D-0697-2021
Class II · Moderate risk Terminated

Zyprexa Intramuscular

Reason cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.

Eli Lilly & Company NDC 0002-7597-01 D-0720-2021
Class II · Moderate risk Terminated

Xylocaine-MPF with Epinephrine 1:200

Reason Low out of specification results for epinephrine assay.

Fresenius Kabi USA LLC NDC 63323-487-07 D-0651-2021
Class II · Moderate risk Terminated

Acetaminophen 325 mg tablets

Reason cGMP deviations: Discolored acetaminophen

Spirit Pharmaceuticals NDC 79903-052-10 D-0729-2021
Class II · Moderate risk Terminated

Xolair

Reason Failed Stability Specifications: Out of Specification results of Polysorbate 20 (PS20) content were detected at the 12 month testing time point.

Genentech Inc D-0650-2021
Class II · Moderate risk Terminated

QiYu Hand Sanitizer Gel

Reason Subpotent

World Source Llc D-0632-2021
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended-Release Tablets

Reason CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Viona Pharmaceuticals INC NDC 72578-036-01 D-0640-2021
Class II · Moderate risk Terminated

DermOtic Oil

Reason Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.

Hill Dermaceuticals, Inc. NDC 68791-103-20 D-0637-2021
Class II · Moderate risk Terminated

Diflorasone Diacetate Ointment USP

Reason Presence of Foreign Substance: Foreign particles observed during routine stability testing.

Teligent Pharma, Inc. NDC 52565-063-15 D-0636-2021
Class II · Moderate risk Terminated

Native Fluoride Toothpaste for Sensitive Teeth

Reason Labeling: Not Elsewhere Classified; the primary label (tube) may be incorrectly labeled as Fluoride-Free instead of With Fluoride

Accupac, Inc. D-0598-2021